Tower Research Capital LLC (Trc) Lexaria Bioscience Corp. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Lexaria Bioscience Corp. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,344 shares of LEXX stock, worth $3,104. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,344
Previous 3,370
60.12%
Holding current value
$3,104
Previous $9,000
55.56%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding LEXX
# of Institutions
27Shares Held
1.06MCall Options Held
0Put Options Held
0-
Invenomic Capital Management LP Boston, MA476KShares$1.1 Million0.08% of portfolio
-
Geode Capital Management, LLC Boston, MA150KShares$347,4030.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA109KShares$251,8400.0% of portfolio
-
Gen Trust, LLC60KShares$138,6000.01% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL44.9KShares$103,7190.0% of portfolio
About Lexaria Bioscience Corp.
- Ticker LEXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,951,000
- Market Cap $13.7M
- Description
- Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x ...